Abeona Therapeutics Inc.
ABEO
$4.48
-$0.47-9.50%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -63.73M | -71.03M | -52.60M | -76.66M | -54.19M |
| Total Depreciation and Amortization | 2.91M | 2.85M | 2.88M | 3.03M | 3.20M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.20M | 19.02M | 4.51M | 36.41M | 15.77M |
| Change in Net Operating Assets | -4.38M | 468.00K | 3.01M | -2.59M | -1.79M |
| Cash from Operations | -56.02M | -48.69M | -42.20M | -39.80M | -37.01M |
| Capital Expenditure | -2.45M | -1.88M | -1.52M | -838.00K | -331.00K |
| Sale of Property, Plant, and Equipment | 18.00K | 35.00K | 43.00K | 204.00K | 204.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -36.81M | -44.75M | -57.69M | -9.19M | 335.00K |
| Cash from Investing | -39.24M | -46.59M | -59.16M | -9.82M | 208.00K |
| Total Debt Issued | 20.00M | 20.00M | 20.00M | 20.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 85.63M | 87.90M | 110.88M | 43.81M | 37.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.49M | -1.61M | -1.31M | -1.31M | -332.00K |
| Cash from Financing | 104.14M | 106.29M | 129.57M | 62.50M | 37.06M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 8.88M | 11.01M | 28.20M | 12.88M | 256.00K |
